Here are four things to know:
1. Mr. Davis has been involved in the life sciences industry for 25 years. His previous role was as CEO of Arlington, Tenn.-based MicroPort Orthopedics.
2. He succeeds Henry Klyce, who will continue serving the company as chairman of the board.
3. Mr. Davis said, “We have an opportunity to fulfill a significant unmet need in the orthopedic market here in the U.S. and worldwide, helping the millions of patients with persistent knee pain following meniscectomies.”
4. One of Active Implants’ notable products, the NUsurface Meniscus Implant is an investigational treatment for patients suffering from consistent knee pain following medial meniscus surgery.
More device articles:
Exactech 2016 revenue up 7% to $257.6M: 7 things to know
Medtronic’s Q3 revenue up 5%, spine revenue growth strongest in 7+ years: 7 key notes
GS Medical U.S.A. to release several new spine devices — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
